Following Cathie Wood: Picking up the knife! She aggressively bought 160,000 shares of Circle amid a 20% plunge and reduced her Bullish holdings by 40,000 shares.

Overnight, under the influence of conflicting news from the Middle East, the three major U.S. stock indexes resumed their decline. At the close, the S&P 500 fell 0.37% to 6,556.37 points; the Nasdaq Composite dropped 0.84% to 21,761.89 points; and the Dow Jones Industrial Average fell 0.18% to 46,124.06 points.

Against this backdrop, Cathie Wood not only executed an extreme 'keep the strong, discard the weak' strategy in the crypto/fintech space but also mercilessly cut positions in traditional finance, legacy streaming media, and some medical device stocks.

Buying direction: Bottom-fishing stablecoin issuer Circle.

Overnight, Cathie Wood bottom-fished the stablecoin issuer $Circle (CRCL.US)$ with a massive purchase of 161,500 shares.As the latest draft of the Clarity Act suggests potential restrictions on stablecoin balance returns, Circle's share price plummeted over 20% in a single day. Amid market panic selling, Cathie Wood made a precise move to 'catch the falling knife.'

The core logic behind this is that ARK’s long-term valuation of Circle has never been as a 'shadow bank' earning interest spreads, but rather as the underlying infrastructure for the next generation of global frictionless digital clearing networks. Even if the bill limits some yields, USDC’s massive network effect as a payment medium still exists. Taking advantage of the irrational crash triggered by regulatory fears, the large purchase of 160,000 shares is a high-probability bet on the "payment channel value."

Previously,'Wood姐' continued to increase her position in single-cell sequencing giant $10x Genomics (TXG.US)$ by 22,500 shares, while also adding to her stake in mRNA newcomer $Arcturus Therapeutics (ARCT.US)$ 4,525 shares.

The continuous buying of TXG fully confirms the previous 'reversal revaluation' logic. While selling off other medical tools, ARK has shown exclusive favor to TXG, which controls the underlying spatial omics data, and ARCT, which holds the ability to rewrite mRNA's underlying instructions. This indicates that ARK’s endgame thinking in the healthcare sector is very clear: only companies that monopolize micro-level data sources or master curative therapies deserve a valuation premium in the AI era.

Sell-side move: Reduced position in the cryptocurrency exchange Bullish

The sell-side activity that day was akin to a 'mass clean-up,' spanning multiple sectors including traditional finance, biotools, legacy tech, and semiconductor hardware.

Cathie Wood heavily sold shares of a South African financial services group $DISCOVERY LIMITED UNSP ADR EACH REP 3 ORD SHS (DCYHY.US)$ as much as 264,900 shares, while slightly reducing the stake in a European payment giant $Adyen N.V. Unsponsored ADR (ADYEY.US)$ . Selling over 260,000 shares of a traditional insurance/financial services giant while simultaneously purchasing 160,000 shares of Circle represents a textbook example of 'crossing from the old to the new era.' The bloated structure of traditional finance is being disrupted by efficient blockchain-based payment networks, with capital voting with its feet.

Additionally, she reduced her holdings in the cryptocurrency exchange $Bullish (BLSH.US)$ by 41,100 shares. This formed a perfect capital loop with the purchase of Circle.

In addition, she heavily cut positions in a synthetic biology company $Twist Bioscience (TWST.US)$ 190,100 shares sold, unloading genomic diagnostics company $Veracyte (VCYT.US)$ 44,600 shares reduced, trimming gene-editing company $Beam Therapeutics (BEAM.US)$ 27,700 shares; slightly reduced ROKU (streaming veteran) by 54,600 shares, TER (testing equipment supplier) by 18,600 shares, and Taiwan Semiconductor (leading foundry) by 3,148 shares.

Futubull's [Opportunities Page] has launched a feature to track celebrity portfolio opportunities! Choose from multiple celebrity portfolios, one-click follow the moves of top investors, precisely lock in high-quality stocks, and invest with greater confidence!

522K Views